MD vs NHC
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
MD · Pediatrix Medical$31.29 ▼ 1.73%
NHC · National Healthcare$208.85 ▲ 0.59%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- MD +38.6%
- NHC +62.1%
Head to head
| Metric | MD | NHC |
|---|---|---|
| Price | $31.29 | $208.85 |
| Change today | ▼ 1.73% | ▲ 0.59% |
| Market cap | $2.44B | $3.27B |
| Return, 3 months | +20.0% | -5.2% |
| Return, year to date | +46.3% | +53.9% |
| Return, 1 year | +42.7% | +66.7% |
| P/E (TTM) | 17.1 | 28.9 |
| P/B | 2.9 | 2.9 |
| P/E percentile vs own 5y | 79th | 57th |
| Dividend yield | – | 1.25% |
| Revenue growth (YoY, latest qtr) | +1.7% | +8.8% |
| Net profit growth (YoY) | -34.5% | +68.1% |
| Gross margin | 26.1% | 39.5% |
| Operating margin | 12.1% | 9.3% |
| Net margin | 7.7% | 9.0% |
| Return on equity | 17.2% | 13.1% |
| Analyst target vs. price | -12.4% | – |
| Analyst buy share | 17% | – |
| RSI (14) | 67 | 41 |
| 30-day volatility | 32.8% | 41.7% |
| Max drawdown, 1 year | -23.7% | -18.5% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Hold | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NHC is the largest of the group by market value.
- NHC has returned the most over the past year.
- MD carries the lowest trailing P/E.
- NHC is growing revenue fastest.
- NHC keeps the most profit per dollar of sales.
- MD has been the calmest stock over the last 30 days.